Inhibition of endothelial cell survival and angiogenesis by protein kinase A - Wikidata - awgldk - TriplyDB

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

http://www.wikidata.org/entity/Q34797701

about

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain Endothelial integrins and angiogenesis: not so simple anymore A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis Mtmr8 is essential for vasculature development in zebrafish embryos.Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.Extracellular matrix modulates angiogenesis in physiological and pathological conditions.CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.An IP-10 (CXCL10)-derived peptide inhibits angiogenesis.A novel interplay between Rap1 and PKA regulates induction of angiogenesis in prostate cancer.A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting.PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines T-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via alphavbeta3 and alpha5beta1 integrins.Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1.CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.Apoptotic cues from the extracellular matrix: regulators of angiogenesis.Integrins: roles in cancer development and as treatment targets.Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis.Synergistic control of cell adhesion by integrins and syndecans.Localized alpha4 integrin phosphorylation directs shear stress-induced endothelial cell alignment.Integrins in angiogenesis and lymphangiogenesis alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.Inhibition of angiogenesis by extracellular protein kinase A.Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models.The development of peptide-based interfacial biomaterials for generating biological functionality on the surface of bioinert materials.Emerging therapeutic approaches in the management of retinal angiogenesis and edema.Volociximab in cancer.

P2860

Q24303828-15675450-DCF2-441C-B6E8-59A53D8CC7E5 Q24305068-4199893C-54DD-42EF-84E1-F12B696179EB Q24553319-59684E78-A6D7-407D-9935-0ED08F176675 Q27320446-B665E553-56D9-40B6-AF7D-6B88702A66BD Q28246151-63637B89-CCFC-441C-B566-05ECBFEB4F25 Q28509980-6DD9E0BF-E70D-46CA-B571-4872DB229F49 Q30480495-29782A32-0204-42AA-8913-5389C6636AC3 Q30496686-3E262C1B-265E-4D94-B68D-9CF2AE361493 Q33654192-85C8F290-DBF6-409D-858F-C6789566A23E Q33737210-D76BDE68-BBA5-48C3-88AC-7C8ABB6550A9 Q33816432-D97C7200-DE70-4602-AD30-D553C455F769 Q33894448-C29DD4B9-AA49-4019-82B1-F976D5178F3A Q34345236-27B444B3-2FBF-4114-943B-B42AFDEB038C Q34482857-D390FF95-5535-473E-907C-A719CA9A4AB2 Q34541791-CBA12CE3-3DDB-40A5-B4EC-B9EACFED18D7 Q34541955-4AD43E21-65F6-4290-9DC9-81A33F53F6DE Q34701752-F8E9F32B-66E4-4E8B-B29C-2B789C3F5EBC Q34774929-4DD9EF00-8FC7-41D3-B209-5FF98D8C2E60 Q35042977-58326DB6-ABB4-410E-B30A-DA37F739B653 Q35084870-AE91855B-00A1-4E92-9DDD-858D02CC8BA8 Q35108230-53DD6EA0-0C2C-4370-856F-4722A0CAAF7E Q35469531-30F30839-1321-4DFF-B8FF-0EA10F52C59B Q35591666-0C1D01E9-BB27-4B98-B249-A88B58D989EA Q35603378-267B8155-FA3F-4421-A9F1-BB09CE482CED Q35647842-874BD9D8-C5B0-4746-BA99-903619F78DB6 Q36042713-E5CA5409-345C-4418-923F-3ECCF72D4D7A Q36087887-47C9C9D5-B29B-4363-B97D-5B2AD92F248F Q36104744-900C6665-9085-4DFA-986F-CACEBA835221 Q36449359-9016BF33-CD96-4BC5-AFD1-B383FAD70EC6 Q36499129-0703CC4B-4F2A-4581-BBD6-D679D94DD64D Q36920817-8CC03ADA-EED6-41B3-9E8A-313A4CF90A78 Q36986535-7D523B88-1ABE-4577-A53C-DE26B5DF45D9 Q37160157-A2789583-472C-4FC0-A918-1E7AAC109465 Q37170752-D14E7074-4CB1-460A-8393-7559210DD899 Q37197423-6EAEA446-E3DC-4CFA-A203-A09D0A0287B3 Q37270000-3FC3A773-729B-437C-A21B-B365AD0660E5 Q37403111-206AEF6B-6CC8-48D2-9895-84F4C89F966A Q37427219-4FC5EA40-DCBE-4A78-B57F-59CC5282F4AE Q37822290-81A97C1F-20BD-47A1-BC33-59AAB5DF627F Q37970775-608825B2-DC40-402C-9A90-5D6F9577BD74

P2860

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

http://www.wikidata.org/entity/Q34797701

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@ast

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@en

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@nl

type

label

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@ast

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@en

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@nl

prefLabel

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@ast

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@en

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@nl

P1433

Q34797701-94FA06A4-681D-4186-99AF-1FE4A7D1E79D

P1476

Q34797701-7BCC6F6E-B766-416A-9D2E-F8EB918F5942

P2093

Q34797701-0EE4C81B-EF3F-43FE-8DC6-8300A5F72337

Q34797701-49C5FBF1-B15C-4C63-A0BA-36D4C4B7D5EF

Q34797701-A39065C4-CCDD-439F-A676-19F5BB7980C9

Q34797701-CF0EB044-7318-434E-974C-ECEE82604842

P2860

Q34797701-07AA9DD5-5579-4C67-AFEA-9F5E9157DE16

Q34797701-18426690-3659-4DC1-AC19-E64A729CB216

Q34797701-18FCFFBA-EDC0-47FB-8B80-605B6FDD781B

Q34797701-226D2537-A092-4816-95A7-79E02618DF3A

Q34797701-2BB6ED3B-38D9-4F77-B875-F3AA80086C61

Q34797701-2BBB5516-8C88-4F5B-9515-84CD042F4F1B

Q34797701-2D1549B9-9769-4953-BC42-F5F408C34543

Q34797701-2DCABD78-E4C4-4B8D-9646-5020D89A101D

Q34797701-37966A85-C5DC-439A-B173-AB7DDB0C1E41

Q34797701-39B6D2A2-EE64-44B7-A602-54B10B404D7D

P304

Q34797701-9CAC6DC0-6A8A-427B-B9BB-F9C0685A28C4

P31

Q34797701-F15D760D-0C3A-4A3F-BD2B-7C75ACE423B0

P356

Q34797701-6947F95B-AEF6-4E15-BFD7-FDBD7B31A661

P407

Q34797701-49CF984C-D74D-4549-967A-24518389D943

P433

Q34797701-3D87FAA4-9047-425B-9F4C-13820E4137AD

P478

Q34797701-799DAC38-E4C5-46F0-B50E-C2390DDCD04C

P577

Q34797701-F0197683-2FDF-4C48-B4F2-C5AA2A548405

P698

Q34797701-DFAF1DDC-DF3B-486A-97BD-F7894C5B770B

P921

Q34797701-A19ABACE-5FCF-48EE-B2B7-1DEBE19C2B8F

P932

Q34797701-E85D4B6C-61F9-4643-A9DC-8440AA91DA5A

P356

P1433

Journal of Clinical Investigation

P1476

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

@en

P2093

Hong Yin

http://www.w3.org/2001/XMLSchema#string

Judith A Varner

http://www.w3.org/2001/XMLSchema#string

Manjiri Bakre

http://www.w3.org/2001/XMLSchema#string

Semi Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of epithelial cell-matrix interactions induces apoptosis

Death receptors: signaling and modulation

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

Caspases: enemies within

Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Requirement of vascular integrin alpha v beta 3 for angiogenesis

A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.

P304

933-941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0214268

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12370271

http://www.w3.org/2001/XMLSchema#string

P921

P932

151143

http://www.w3.org/2001/XMLSchema#string